| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.77B | 29.16B | 17.35B | 15.45B | 16.93B | 19.47B |
| Gross Profit | 19.64B | 24.77B | 12.94B | 11.46B | 13.30B | 16.18B |
| EBITDA | 21.52B | 22.82B | 22.15B | 20.87B | 15.48B | 16.34B |
| Net Income | 15.44B | 17.75B | 13.05B | 11.86B | 10.08B | 12.54B |
Balance Sheet | ||||||
| Total Assets | 424.87B | 580.77B | 381.63B | 341.18B | 406.05B | 399.30B |
| Cash, Cash Equivalents and Short-Term Investments | 282.46B | 318.26B | 230.91B | 224.70B | 276.39B | 342.33B |
| Total Debt | 1.27B | 1.89B | 1.75B | 1.60B | 2.24B | 2.48B |
| Total Liabilities | 367.42B | 522.05B | 327.22B | 289.38B | 355.95B | 349.39B |
| Stockholders Equity | 56.91B | 58.15B | 53.85B | 51.34B | 49.73B | 49.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.96B | 11.17B | 10.11B | 13.67B | 11.27B |
| Operating Cash Flow | 0.00 | 22.70B | 12.77B | 11.50B | 14.96B | 12.34B |
| Investing Cash Flow | 0.00 | -7.74B | 3.19B | -6.29B | -1.70B | 2.28B |
| Financing Cash Flow | 0.00 | -14.59B | -11.26B | -11.25B | -10.37B | -12.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$501.11B | 29.02 | 32.11% | 2.66% | 35.41% | 29.82% | |
68 Neutral | HK$139.68B | 10.56 | 8.83% | 0.97% | 64.00% | 112.84% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | HK$415.77B | 12.45 | 10.28% | 2.05% | 62.72% | 29.18% | |
58 Neutral | HK$310.83B | 8.69 | 8.71% | 2.75% | 52.67% | 121.43% | |
57 Neutral | HK$171.60B | 9.77 | 8.46% | 2.92% | 10.82% | 55.25% | |
53 Neutral | HK$168.88B | 9.66 | 10.70% | 2.80% | 36.57% | 77.14% |